Gestational diabetes mellitus identifies women with a 7- to 10-fold higher risk of type 2 diabetes and a 2-fold higher risk of cardiovascular disease, providing an opportunity for primary prevention.
Gestational diabetes identifies women at elevated lifetime risk for type 2 diabetes and cardiovascular disease, presenting a critical window for early preventive interventions.
Gestational diabetes mellitus (GDM), which has traditionally been defined as glucose intolerance of varying severity with first onset in pregnancy, is rising in prevalence with maternal hyperglycemia currently affecting one in every six pregnancies worldwide. Although often perceived as a medical complication of pregnancy, GDM is actually a chronic cardiometabolic disorder that identifies women who have an elevated lifetime risk of ultimately developing type 2 diabetes and cardiovascular disease. In identifying high-risk women early in the natural history of these conditions, the diagnosis of GDM raises the tantalizing possibility of early intervention and risk modification. However, before such promise can be realized in practice, a series of clinical challenges/obstacles (reviewed herein) must be overcome. Ultimately, the coupling of this life course perspective of GDM with concerted efforts to overcome these challenges may enable fulfilment of this unique opportunity for the primary prevention of diabetes and heart disease in women.
Fu et al. (2022) conducted a review in Gestational diabetes mellitus. Gestational diabetes mellitus identifies women with a 7- to 10-fold higher risk of type 2 diabetes and a 2-fold higher risk of cardiovascular disease, providing an opportunity for primary prevention.